Vanberra Signal

Artera

Curated by Signal

AI-derived prognostic biomarker test for cancer detection

Overview

AI-derived prognostic biomarker test for cancer detection. The company offers an AI-enabled test called the ArteraAI prostate test, which provides predictive and prognostic results for patients with localized prostate cancer. The test analyzes multiple characteristics of the individual patient, empowering doctors with personalized data for treatment planning.

Key facts

Founded
2021

Business model

Contact

Open roles

29 roles
  • Customer Success Representative I (West Coast Region)

    United States · On-site · Volunteer

  • Chief Medical Officer (CMO)

    United States · On-site · Volunteer

  • Senior Medical Science Liaison - Western US

    United States · On-site · Volunteer

+ 26 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of cannabis-derived nutritional and wellness products

    Health TechnologyBurbank, United States
  • Provider of data analysis and management software for healthcare professionals

    Health TechnologyRoswell, United States
  • Provider of an application for live coaching for athletes and fitness enthusiasts

    Health TechnologyNew York City, United States

About Artera

What does Artera do?

AI-derived prognostic biomarker test for cancer detection.

Where is Artera headquartered?

Artera is headquartered in Menlo Park, United States.

When was Artera founded?

Artera was founded in 2021.

Which sector is Artera in?

Artera operates in Health Technology.

Who are Artera's competitors?

Companies similar to Artera include MODAE Wellness, HealthWise Data, and AARMY.

Is Artera hiring?

Yes. Artera has 29 open roles listed on Vanberra Signal.